Literature DB >> 3392652

Reinforcing effects of caffeine in humans.

R R Griffiths1, P P Woodson.   

Abstract

The reinforcing and subjective effects of caffeine were studied under double-blind conditions in 12 normal humans. After 2 forced exposure days on which subjects received color-coded capsules containing either caffeine (100, 200, 400 or 600 mg) or placebo, subjects had a choice day on which they chose which one of the two types of color-coded capsules would be ingested. Subjects were exposed to 10 experimentally independent choices (i.e., involving exposure and choice between novel color-coded capsule conditions) at each of several dose levels. All forced exposure and choice opportunities occurred when subjects were overnight abstinent from their normal dietary caffeine intake (mean, 116 mg/day). Significant caffeine positive reinforcement was demonstrated in 5 of 12 subjects at one or more doses. Percentage of selection of caffeine was inversely related to dose, with four subjects showing significant caffeine avoidance at 400 and/or 600 mg. Choice behavior was correlated positively with feelings of contentedness and was correlated negatively with prestudy trait anxiety scores and with ratings of capsule disliking. Compared to placebo, caffeine produced increases in subjective ratings indicating arousal while producing decreases in headache and "craving" for caffeine-containing foods, even at the lowest dose of 100 mg. At higher doses caffeine produced dysphoric anxiety-like subjective effects. Overall, this study provides the first demonstration in humans of the positive reinforcing effects of caffeine alone (i.e., in capsules) and documents individual differences among normal subjects in both caffeine positive reinforcement and caffeine avoidance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3392652

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  29 in total

Review 1.  Genetics of caffeine consumption and responses to caffeine.

Authors:  Amy Yang; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

2.  Low-dose caffeine discrimination and self-reported mood effects in normal volunteers.

Authors:  K Silverman; R R Griffiths
Journal:  J Exp Anal Behav       Date:  1992-01       Impact factor: 2.468

Review 3.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

4.  Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine.

Authors:  Stacey C Sigmon; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2011-05-19       Impact factor: 4.492

5.  Influence of caffeine on the liking of novel-flavored soda in adolescents.

Authors:  Jennifer L Temple; Amanda M Ziegler; Adam Graczyk; Ashley Bendlin; Shannon O'Leary; Yasemin S Schnittker
Journal:  Psychopharmacology (Berl)       Date:  2012-03-20       Impact factor: 4.530

6.  Reinforcing and subjective effects of caffeine in normal human volunteers.

Authors:  K N Stern; L D Chait; C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors.

Authors:  M El Yacoubi; C Ledent; J F Ménard; M Parmentier; J Costentin; J M Vaugeois
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

8.  Adenosine A1 and A2A receptors are not upstream of caffeine's dopamine D2 receptor-dependent aversive effects and dopamine-independent rewarding effects.

Authors:  Jessica E Sturgess; Ryan A Ting-A-Kee; Dominik Podbielski; Laurie H L Sellings; Jiang-Fan Chen; Derek van der Kooy
Journal:  Eur J Neurosci       Date:  2010-06-22       Impact factor: 3.386

9.  The interoceptive Pavlovian stimulus effects of caffeine.

Authors:  Jennifer E Murray; Chia Li; Matthew I Palmatier; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

Review 10.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.